Soluble Urokinase Receptor and Acute Kidney Injury
Salim S. Hayek(Emory University), Jochen Reiser(University of Miami), David E. Leaf(Brigham and Women's Hospital), Sanja Sever(Harvard University), Steven D. Weisbord(Brigham and Women's Hospital), Jenny S. Pan(University of Pittsburgh), Michael W. Holliday(Brigham and Women's Hospital), Alexander Camacho(Brigham and Women's Hospital), James L. Januzzi(Harvard University), Shreyak Sharma(Brigham and Women's Hospital), Ranadheer R. Dande(Brigham and Women's Hospital), Sushrut S. Waikar(Boston University), Changli Wei(University of Miami), Nasrien E. Ibrahim, Mehmet M. Altintas(Rush University Medical Center), Rebecca M. Baron(Brigham and Women's Hospital), Xuexiang Wang(Soochow University), Arshed A. Quyyumi(Emory University), Mohamad Raad(Brigham and Women's Hospital), Ayman Samman Tahhan(Emory University), David Sheikh‐Hamad(Michael E. DeBakey VA Medical Center)
Cited by 204
Related Papers
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k
The N-terminal Pro-BNP Investigation of Dyspnea in the Emergency department (PRIDE) study
|The American Journal of Cardiology|2005|1.2k
Factors Associated With Death in Critically Ill Patients With Coronavirus Disease 2019 in the US
|JAMA Internal Medicine|2020|1k
SARS-CoV-2 viral load is associated with increased disease severity and mortality
|Nature Communications|2020|978
Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis
|Nature Medicine|2011|834